Two-fraction stereotactic ablative radiotherapy (SABR) versus two-fraction high dose rate (HDR) brachytherapy for localized prostate cancer: Does dose heterogeneity matter?-Reference-Cited by-同舟云学术

Two-fraction stereotactic ablative radiotherapy (SABR) versus two-fraction high dose rate (HDR) brachytherapy for localized prostate cancer: Does dose heterogeneity matter?

Published:2022-04 Issue: Volume:169 Page:51-56
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Correa Rohann J.M.,Morton Gerard,Chung Hans T.,Tseng Chia-Lin,Cheung Patrick,Chu William,Liu Stanley K,McGuffin Merrylee,Shahid Anam,Davidson Melanie,Ravi Ananth,Helou Joelle,Alayed Yasir,Zhang Liying,Mamedov Alexandre,Loblaw Andrew

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference21 articles.

1. Diminishing returns from ultrahypofractionated radiation therapy for prostate cancer;Vogelius;Int J Radiat Oncol Biol Phys,2020

2. Outcomes associated with 3 treatment schedules of high-dose-rate brachytherapy monotherapy for favorable-risk prostate cancer;Jawad;Int J Radiat Oncol Biol Phys,2016

3. High-dose-rate monotherapy for localized prostate cancer: 10-year results;Hauswald;Int J Radiat Oncol Biol Phys,2016

4. Single-dose high-dose-rate brachytherapy compared to two and three fractions for locally advanced prostate cancer;Hoskin;Radiother Oncol,2017

5. Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy;Morton;Radiother Oncol,2020

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and manufacturing of a phantom for quality control of high dose rate Cobalt-60 source used in gynecologic brachytherapy;Radiation Physics and Chemistry;2024-11

2. Predictive value of magnetic resonance imaging diffusion parameters using artificial intelligence in low-and intermediate-risk prostate cancer patients treated with stereotactic ablative radiotherapy: A pilot study;Radiography;2024-05

3. Radiotherapy in localized prostate cancer: a multicenter analysis evaluating tumor control and late toxicity after brachytherapy and external beam radiotherapy in 1293 patients;Strahlentherapie und Onkologie;2024-03-15

4. Response to comment to “Dosimetric correlates of toxicities and quality of life following two-fraction stereotactic ablative radiotherapy (SABR) for prostate cancer”;Radiotherapy and Oncology;2023-12

5. The march toward single-fraction stereotactic body radiotherapy for localized prostate cancer—Quo Vadimus?;World Journal of Urology;2023-11-03